Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Poullis

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
The Journal of Thoracic and Cardiovascular Surgery|August 5, 2000
The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1M Poullis, R Manning, M Laffan, et al.
The Heart Surgery Forum|February 15, 2001
Effect of aprotinin (trasylol) on the inflammatory and thrombotic complications of conventional cardiopulmonary bypass surgeryR C Landis, G Asimakopoulos, M Poullis, et al.
Heart (British Cardiac Society)|June 18, 2004
Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary interventionJ R S Day, I S Malik, A Weerasinghe, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
The Journal of Thoracic and Cardiovascular Surgery|August 5, 2000
The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1M Poullis, R Manning, M Laffan, et al.
The Heart Surgery Forum|February 15, 2001
Effect of aprotinin (trasylol) on the inflammatory and thrombotic complications of conventional cardiopulmonary bypass surgeryR C Landis, G Asimakopoulos, M Poullis, et al.
Heart (British Cardiac Society)|June 18, 2004
Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary interventionJ R S Day, I S Malik, A Weerasinghe, et al.
Pageof 5